In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 20, Issue 12, 2005, Pages 2661-2669

  Nangaku, Masaomi ^a   Izuhara, Yuko ^b   Usuda, Nobuteru ^c   Inagi, Reiko ^b   Shibata, Takeo ^b   Sugiyama, Satoshi ^c   Kurokawa, Kiyoshi ^b   van Ypersele de Strihou, Charles ^d   Miyata, Toshio ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Advanced glycation end product; Multiple risk factor intervention; Pentosidine; Proteinuria; Renoprotection

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; PENTOSIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATORY CELL; KIDNEY INJURY; LOW CALORY DIET; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ARGININE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIET, FAT-RESTRICTED; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; KIDNEY; LYSINE; MALE; MICROSCOPY, ELECTRON; OBESITY; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 27944496510     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi096     Document Type: Article

References (39)

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341: 1127-1133
2. Remuzzi G, Schieppati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145-1151
3. Patrick DH, Hansen CT, Canary JJ, Werner RM, Carswell N. Insulin-independent diabetes mellitus (type II) spontaneous hypertensive/ NIH corpulent rat. Am J Pathol 1986; 123: 398-400
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee of the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S4-S20
5. Meigs JB. The metabolic syndrome. Br Med J 2003; 327: 61-62
6. Dominiczak MH. Metabolic syndrome. Curr Opin Lipidol 2003; 14: 329-332
7. Dominiczak MH. Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine. Clin Chem Lab Med 2003; 41: 1266-1278
8. John WG, Edwards R, Price CP. Laboratory evaluation of the DCA 2000 clinic HbA1c immunoassay analyser. Ann Clin Biochem 1994; 31: 367-370
9. Uehara Y, Hirawa N, Kawabata Y et al. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension 1994; 24: 770-778
10. Nangaku M, Miyata T, Sada T et al. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1212-1222
11. Miyata T, Ueda Y, Shinzato T et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996; 7: 1198-1206
12. Floege J, Alpers CE, Sage EH et al. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 1992; 67: 486-497
13. Johnson RJ, Iida H, Alpers CE et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991; 87: 847-858
14. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135: 719-733
15. Horie K, Miyata T, Maeda K et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 1997; 100: 2995-3004
16. Suzuki D, Miyata T, Saotome N et al. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 1999; 10: 822-832
17. Miyata T, Taneda S, Kawai R et al. Identification of pentosidine as a native structure for advanced glucation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 1996; 93: 2353-2358
18. Miyata T, Sugiyama S, Saito A, Kurokawa K. Reactive carbonyl compounds related uremic toxicity ('carbonyl stress'). Kidney Int 2001; 59 [Suppl 78]: S25-S31
19. Miyata T, Kurokawa K, van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int 2000; 58 [Suppl 76]: S120-S125
20. Miyata T, Ueda Y, Yamada Y et al. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end products: carbonyl stress in uremia. J Am Soc Nephrol 1998; 9: 2349-2356
21. Jadoul M, Ueda Y, Yasuda Y et al. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of 'carbonyl stress'. Kidney Int 1999; 55: 2487-2492
22. Miyata T, van Ypersele de Strihou C, Ueda Y et al. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: Biochemical mechanisms. J Am Soc Nephrol 2002; 13: 2478-2487
23. Price DA, Lansang MC, Osei SY et al. Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabetic Med 2002; 19: 858-861
24. Sowers JR, Nyby M, Stern N et al. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982; 4: 686-691
25. Nosadini R, Tonolo G. Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. J Am Soc Nephrol 2004; 15: S1-S5
26. Segura J, Campo C, Roldan C et al. Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances. J Am Soc Nephrol 2004; 15: S37-S42
27. Hoshi S, Shu Y, Yoshida F et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 2002; 82: 25-35
28. Coimbra TM, Janssen U, Grone HJ et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167-182
29. Grone HJ, Walli A, Grone E et al. Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. Lab Invest 1989; 60: 433-446
30. Michel O, Heudes D, Lamarre I et al. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney Int 1997; 52: 1532-1542
31. Reisin E, Harris KY, Azar S et al. A low-calorie unrestricted protein diet attenuates kidney damage in uninephrectomized spontaneously hypertensive rats. Am J Nephrol 1999; 19: 433-440
32. Lingelbach LB, Mitchell AE, Rucker RB, McDonald RB. Accumulation of advanced glycation endproducts in aging male Fischer 344 rats during long-term feeding of various dietary carbohydrates. Nutrient Metabolism 2000; 130: 1247-1255
33. Teillet L, Verbeke P, Gouraud S et al. Food restriction prevents advanced glycation end product accumulation and retards kidney aging in lean rats. J Am Soc Nephrol 2000; 11: 1488-1497
34. Morales E, Valero MA, Leon M, Hernandez E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003, 41: 319-327
35. Stern JS, Gades MD, Wheeldon CM, Borchers AT. Calorie restriction in obesity: Prevention of kidney disease in rodents. J Nutr 2001; 131: 913S-917S
36. Hall JE, Brandy MW, Henegar JR, Shek EW. Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 1998; 25: 56-64
37. Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol 2000; 278: F817-F822
38. Gross M-L, Ritz E, Schoof A et al. Renal damage in the SHR/N-cp type 2 diabetes model: Comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker. Lab Invest 2003; 83: 1267-1277
39. Gross M-L, Ritz E, Schoof A et al. Comparison of renal morphology in the streptozotocin and the SHR/N-cp models of diabetes. Lab Invest 2004; 84: 452-464